Governor Wes Moore announced on November 21, 2025, that AstraZeneca, a global biopharmaceutical company, will invest $2 billion to expand its manufacturing footprint across Maryland. The investment ...

AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its previously announced $50 billion plan to expand manufacturing and research ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The expansion, which follows a ...

Biopharmaceutical giant AstraZeneca is expanding its Gaithersburg footprint, taking an entire building at a recently completed industrial park from Matan Cos. The company leased 198K SF, taking one of ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min One of the world's largest ...

CHELMSFORD, Mass. – AstraZeneca, a global biopharmaceutical company, and Axis Communications today announced new surveillance upgrades to AstraZeneca’s research and development (R&D) center in ...

Article ‘Count’ and ‘Share’ for AstraZeneca Gaithersburg, MD based on listed parameters only. The articles listed below published by authors from AstraZeneca Gaithersburg, MD, organized by journal and ...